Tekla Capital Management LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$2,550,719
-37.4%
100,4220.0%0.10%
-37.0%
Q4 2022$4,073,116
-21.4%
100,422
-36.0%
0.15%
-27.4%
Q3 2022$5,185,000
-6.1%
156,8750.0%0.21%
-2.3%
Q2 2022$5,524,000
-10.9%
156,875
+16.4%
0.22%
-0.5%
Q1 2022$6,200,000
-30.6%
134,8120.0%0.22%
-24.3%
Q4 2021$8,938,000
-29.9%
134,812
-34.0%
0.29%
-29.9%
Q3 2021$12,749,000
+15.8%
204,214
+53.7%
0.41%
+14.8%
Q2 2021$11,006,000
+24.9%
132,8860.0%0.36%
+18.2%
Q1 2021$8,812,000
-13.6%
132,8860.0%0.30%
-15.4%
Q4 2020$10,196,000
+219.2%
132,886
+79.1%
0.36%
+198.3%
Q3 2020$3,194,000
-0.3%
74,1860.0%0.12%
-1.6%
Q2 2020$3,204,000
+50.1%
74,1860.0%0.12%
+27.1%
Q1 2020$2,134,000
-68.1%
74,186
-29.6%
0.10%
-62.1%
Q4 2019$6,685,000
+672.8%
105,398
+243.3%
0.25%
+565.8%
Q3 2019$865,000
+6.3%
30,7000.0%0.04%
+15.2%
Q2 2019$814,000
+44.6%
30,7000.0%0.03%
+43.5%
Q1 2019$563,000
+47.8%
30,7000.0%0.02%
+43.8%
Q4 2018$381,00030,7000.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders